Structural details of an attractive drug target in coronaviruses that could be used against SARS-CoV-2 and in future pandemics have been published today in eLife.
Nov 22, 2022
0
66
The growing list of COVID complications is long and surprising—from brain changes and heart disease to skin rashes and COVID toes.
Oct 13, 2022
0
4
An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new Northwestern Medicine study done in mice.
Oct 5, 2022
0
100
Though well-known as a respiratory illness, COVID-19 can also affect the nervous system, bringing on headaches and fatigue and wiping out the sense of smell. But it's unclear whether these symptoms are caused by an immune ...
Sep 21, 2022
0
17
The 15-valent pneumococcal conjugate vaccine (PCV15) can be used for children aged younger than 19 years, according to recommendations issued by the Advisory Committee on Immunization Practices and published in the Sept. ...
Sep 16, 2022
0
12
A combination of two drugs showed promise in treating relapsed or refractory acute myeloid leukemia (AML) with mutations in the FMS-like tyrosine kinase 3 (FLT3) gene, according to a Northwestern Medicine study published ...
Sep 14, 2022
0
33
New study data shows that the immuno-oncology drug, atezolizumab (marketed as Tecentriq) is a safe and effective treatment for stage IB-IIIB non-small cell lung cancer patients prior to lung cancer surgery. This is according ...
Sep 13, 2022
0
71
Ironically, some vaccines need their own "boosters." Adding an ingredient called an adjuvant can help vaccines elicit a more robust immune response, better training the body to fight a pathogen. In a new study in ACS Infectious ...
Aug 31, 2022
0
12
In its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the current "gold standard" treatment for this autoimmune disease. This opens up new treatment ...
Aug 25, 2022
2
97
Pfizer Inc. said Monday that it has asked the U.S. Food and Drug Administration to approve the emergency use of an updated booster shot that targets several versions of the omicron variant.
Aug 23, 2022
0
5
